Pfizer on Tuesday hailed a study of a weight-loss-drug candidate while forecasting a profit decline due to the impact of the Trump administration’s policies on pricing and tariffs.
Trending
- Property manager arrested in connection with possible Las Vegas bio lab faces federal firearm charge
- How To Watch It On Broadcast, On Cable TV & On Streaming
- Dyson’s Thinnest and Lightest Cordless Vacuum Ever Is Finally Ready to Buy in the US
- Iran internet disruption drains $1.56 million hourly from economy, analyst says
- Disney names Josh D’Amaro to replace Bob Iger as CEO : NPR
- What Is the Plot of Zendaya and Robert Pattinson’s Movie The Drama ?
- An ‘Intimacy Crisis’ Is Driving the Dating Divide
- Trump and Warsh aren’t holding a joint press conference. What this says about the Fed’s next chapter.
Wednesday, February 4
Pfizer says once-a-month weight-loss drug works as it forecasts profit decline
